Jan 11 (Reuters) - U.S. drug distributor McKesson MCK.N is planning to sell Canadian drugstore chain Rexall, The Globe and Mail reported on Thursday, citing sources familiar with the sales process.
McKesson bought Rexall Health from Katz Group in 2016 to strengthen its position in Canada's pharmaceutical supply chain. The deal was valued at about C$3 billion ($2.24 billion) at that time.
Rexall did not immediately respond to a Reuters request for comment, while McKesson declined to comment.
McKesson has been in contact with prospective buyers for Rexall, the report said.
There is no guarantee a deal will be completed, according to the report, adding that if a sale is completed, McKesson could remain a Rexall partner by supplying the chain through its pharmaceutical distribution arm.
($1 = 1.3381 Canadian dollars)
(Reporting by Harshita Meenaktshi in Bengaluru; Editing by Rashmi Aich)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.